Key stats
About VANECK BIONIC ENGINEERING UCITS ETF
Expense ratio
0.55%
Home page
Inception date
Dec 2, 2022
ISIN
IE0005TF96I9
Functions as an open-end investment fund
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.88%
Health Technology95.58%
Distribution Services2.32%
Electronic Technology1.98%
Bonds, Cash & Other0.12%
Cash0.12%
Stock breakdown by region
North America82.04%
Europe13.51%
Oceania4.45%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history